Inventor
MOLLARD PAUL
US39 patents
⚠️ This page may combine multiple inventors who share the name “MOLLARD PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PTC THERAPEUTICS INC
11 patentsUS11174212B2Nov 16, 2021
2,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
PTC THERAPEUTICS INC5 citations79
US11304914B2Apr 19, 2022
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
PTC THERAPEUTICS INC2 citations71
US10751302B2Aug 25, 2020
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
PTC THERAPEUTICS INC2 citations71
US11667596B2Jun 6, 2023
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
PTC THERAPEUTICS INC1 citations68
US11186559B2Nov 30, 2021
Methods for enriching alpha-tocotrienol from mixed tocol compositions
PTC THERAPEUTICS INC3 citations68
US10745371B2Aug 18, 2020
Methods for enriching alpha-tocotrienol from mixed tocol compositions
PTC THERAPEUTICS INC2 citations68
US11840497B2Dec 12, 2023
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
PTC THERAPEUTICS INC0 citations62
US10968166B2Apr 6, 2021
4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
PTC THERAPEUTICS INC0 citations62
US11938101B2Mar 26, 2024
Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
PTC THERAPEUTICS INC0 citations60
US11746077B2Sep 5, 2023
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
PTC THERAPEUTICS INC0 citations58
US11560364B2Jan 24, 2023
Methods for enriching alpha-tocotrienol from mixed tocol compositions
PTC THERAPEUTICS INC0 citations58
UGINE KUHLMANN
6 patentsUS4044103AAug 23, 1977
Storage-stable sodium chlorite
UGINE KUHLMANN24 citations81
US4211759AJul 8, 1980
High-density sodium perborate and method of preparation
UGINE KUHLMANN12 citations74
US4018874AApr 19, 1977
Process for the production of sodium percarbonate by atomization
UGINE KUHLMANN9 citations74
US4022874AMay 10, 1977
Process for the production of sodium percarbonate
UGINE KUHLMANN10 citations72
US4004988AJan 25, 1977
Method of preparing sodium chlorate by electrolysis
UGINE KUHLMANN13 citations69
US4190635AFeb 26, 1980
Processes for preparing sodium percarbonate
UGINE KUHLMANN6 citations61
BIOELECTRON TECH CORP
5 patentsUS9932286B2Apr 3, 2018
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
BIOELECTRON TECH CORP3 citations72
US10251847B2Apr 9, 2019
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
BIOELECTRON TECH CORP3 citations71
US10202325B2Feb 12, 2019
Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
BIOELECTRON TECH CORP0 citations52
US10029971B2Jul 24, 2018
Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
BIOELECTRON TECH CORP0 citations52
US10167251B2Jan 1, 2019
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
BIOELECTRON TECH CORP0 citations51
EDISON PHARMACEUTICALS INC
4 patentsUS7968746B2Jun 28, 2011
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
EDISON PHARMACEUTICALS INC46 citations97
US9169196B2Oct 27, 2015
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
EDISON PHARMACEUTICALS INC11 citations92
US9567279B2Feb 14, 2017
Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
EDISON PHARMACEUTICALS INC0 citations52
US9546132B2Jan 17, 2017
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
EDISON PHARMACEUTICALS INC0 citations51
MOLLARD PAUL
2 patentsANVAR
2 patentsCENTRE NAT RECH SCIENT
2 patentsUS4808327AFeb 28, 1989
Compositions of particulate magnetic oxides with a defect spinel structure, preparation thereof and application thereof
CENTRE NAT RECH SCIENT10 citations70
US4803291AFeb 7, 1989
Particulate compositions of ferromagnetic metal oxalates in the form of submicronic acicular particles, the preparation of same and application thereof
CENTRE NAT RECH SCIENT16 citations69